Adjuvant Capital Management, LLC

10% owner at ANTX

Sold, on record
$2M
Dollars the filings state
Form 4 sales
2
Latest Jan 16, 2024
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • ANTXAN2 Therapeutics, Inc.10% owner

Sales by reason

1
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. 1 Form 4 sale ANTXRoutine
    Nov 14, 2023 2023

    Sold 1,810 shares at $16.15 ($29k)

    Adjuvant Capital Management, LLC, 10% owner

    10b5-1 planSold 0.1% of holdings ($33.6M position)2.1M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ANTXNo plan
    Jan 16, 2024 +63 days

    Sold 100,000 shares at $19.65 ($2M)

    Adjuvant Capital Management, LLC, 10% owner

    No 10b5-1 planSold 4.8% of holdings ($41.2M position)2M shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Adjuvant Capital Management, LLC
Source
Jan 16, 2024Jan 18, 2024ANTX10% ownerForm 4 sale100,000$2M4.8%No planSEC
Nov 14, 2023Nov 16, 2023ANTX10% ownerForm 4 sale1,810$29k0.1%RoutineSEC